Responses
Regular and young investigator award abstracts
Combination immunotherapies
463 Metastatic gastric cancer patient benefiting from combined radio-immunotherapy treatment displayed sustained anti-NY-ESO-1 specific T cells and expressed important immuno-modulatory markers
Compose a Response to This Article
Other responses
No responses have been published for this article.